Explore Your Local Site

Looks like you've landed on our   site. Let's take you home:    

Please note that the content and products on the    site might not be available in your region.

 

  Homepage
Continue on the current website:  

 

The Present and Future of Lung Cancer Screening: Latest Evidence and AI Perspectives

The Present and Future of Lung Cancer Screening: Latest Evidence and AI Perspectives

2024-03-13

This webinar aims to review the latest evidence-based insights on lung cancer screening and narrow the knowledge gap regarding lung cancer screening eligibility criteria from a global perspective. Our radiologist and pulmonary medicine experts will not only share insights on lung cancer screening and utilization of AI in lung cancer screening in the US, UK and China but also participate in an interview addressing commonly asked questions about lung cancer screening and the impact of radiology AI.

Radiology
Academy

Medical Education
On Demand

Request a Meeting

The Present and Future of Lung Cancer Screening: Latest Evidence and AI Perspectives

Video title from video component

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Tags

  • #Clinical Utility

Duration

1h 06m 15s

About this webinar

Watch this webinar delving into the world of AI in lung cancer screening.

This webinar aims to review the latest evidence-based insights on lung cancer screening and narrow the knowledge gap regarding lung cancer screening eligibility criteria from a global perspective. Our radiologist and pulmonary medicine experts will not only share insights on lung cancer screening and utilization of AI in lung cancer screening in the US, UK and China but also participate in an interview addressing commonly asked questions about lung cancer screening and the impact of radiology AI.

Speakers

Subrata Bose photo

YYMMDD

Subrata Bose PhD, MBA, MSc, BPharma
Vice President, Diagnostic Imaging, Data & Artificial Intelligence, Head General Clinical Imaging Services at Bayer Ag | MIT | Durham | Imperial

Dr. Christina Biermann photo

YYMMDD

Dr. Christina Biermann
Head of Application Development & Integration, Bayer Pharmaceuticals

Joana Reis photo

YYMMDD

Joana Reis, MD, PhD
Global Medical Affairs Senior Manager for Digital Radiology @Bayer, Senior Consultant Radiologist

References
  1. Cuocolo et al. Eur J Nuc Med Mol Imaging 2010
  2. Boellaard et al, 2015, Eur J Nucl Med Mol Imaging
  3. Antoch et al. JNM 2004
  4. Behrendt et al Eur Rad 2012
  5. Flavell et al. Acad Rad 2014
LinkedIn LinkedIn
Alt tag
  • Global

© 2024 Bayer

The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.

This is intended to provide information for healthcare professionals and other relevant decision makers in the US, European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

 

Calantic is ISO 27001 certified. The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals

 

You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

 

Last Updated: May 2024

Bayer Logo